Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grisham

Showing results (831-840 of 834) with videos related to

Pageof 84
Sort By:
You have reached the last page of results.This site can display upto 834 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Pageof 84

Showing results (831-840 of 834) with videos related to

Sort By:
Pageof 84
You have reached the last page of results.This site can display upto 834 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Pageof 84